Welcome to CDC Stacks | SUPPLEMENTAL FIGURE. Global estimated coverage with 3 doses of diphtheria-tetanus-pertussis vaccine, by country† and gross national income (GNI) per capita - 42377 | Morbidity and Mortality Weekly Report (MMWR)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
SUPPLEMENTAL FIGURE. Global estimated coverage with 3 doses of diphtheria-tetanus-pertussis vaccine, by country† and gross national income (GNI) per capita
  • Published Date:
    November 18, 2016
  • Source:
    Casey RM, Dumolard L, Danovaro-Holliday MC, et al. Global Routine Vaccination Coverage, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1270–1273. DOI: http://dx.doi.org/10.15585/mmwr.mm6545a5.
  • Language:
    English
Filetype[PDF - 225.12 KB]


Details:
No Related Documents.
You May Also Like:
  1. Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Kretsinger, Katrina.; Broder, Karen R.; Cortese, Margaret M.; Joyce, Patricia; Ortega-Sanchez, Ismael; Lee, Grace M.; Tiwari, Tejpratap; Cohn, Amanda C.; Slade, Barbara A.; Iskander, John K.; Mijalski, Christina M.; Brown, Kristin H.; Murphy, Trudy V.;
    Corporate Author:
    National Immunization Program (Centers for Disease Control and Prevention; Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; United States, Advisory Committee on Immunization Practices;
    Published:
    December 15, 2006
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-17):1-37.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. v. 55, no. RR-17
    Description:
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11--64 years (ADACEL®, manufactured by sanofi pasteu...
    Status:
    current
    File Type:
    Filetype[PDF - 418.34 KB]
  2. SUPPLEMENTARY FIGURE 2. Estimated proportion of adults aged ≥19 years who received a tetanus toxoid-containing vaccine (Td or Tdap) and proportion of those who received Tdap, by age group* — National Health Interview Survey, United States, 2010–2015
    Published:
    May 5, 2017
    Source:
    Williams WW, Lu P, O’Halloran A, et al. Surveillance of Vaccination Coverage among Adult Populations — United States, 2015. MMWR Surveill Summ 2017;66(No. SS-11):1–28.
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 66, no. SS-11
    Description:
    Supplementary Figure 2 is a line graph of tetanus toxoid-containing and tetanus, diphtheria, and acellular pertussis (Tdap) vaccination coverage among adults aged ≥19 years by age group over time, where the y-axis represents vaccination coverage ex...
    File Type:
    Filetype[EXCEL - 16.31 KB]
  3. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series : supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Nov 17, 2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-13):1-8.
    Description:
    Four vaccines containing diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) are currently licensed in the United States for use among infants and young children. As of October 2000, two products, ACEL-IMUNE (a product of Lederle La...
    Status:
    current
    File Type:
    Filetype[PDF - 122.95 KB]
  4. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP).
    Corporate Author:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee.
    Published:
    August 08, 1991
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1991; 40(RR-10):1-28.
    Description:
    This revision of the Immunization Practices Advisory Committee (ACIP) statement on diphtheria, tetanus, and pertussis updates the statement issued in 1985, and incorporates the 1987 supplementary statement, which addressed two issues: a) the risks an...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  5. Safety of Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations in Pregnancy
    Personal Author:
    Sukumaran, Lakshmi; McCarthy, Natalie L.; Kharbanda, Elyse O.; Weintraub, Eric; Vazquez-Benitez, Gabriela; McNeil, Michael M.; Li, Rongxia; Klein, Nicola P.; Hambidge, Simon J.; Naleway, Allison L.; Lugg, Marlene M.; Jackson, Michael L.; King, Jennifer P.; DeStefano, Frank; Omer, Saad B.; Orenstein, Walter A.;
    Published:
    Nov 2015
    Source:
    Obstet Gynecol. 126(5):1069-1074.
    Description:
    Objective : To evaluate the safety of co-administering tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) and influenza vaccines during pregnancy by comparing adverse events after concomitant and sequential vaccination. : Metho...
    File Type:
    Filetype[PDF - 256.13 KB]